PBCV-1 RNA Splint Ligase for Rapid DNA Oligonucleotide Ligation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current DNA ligases, such as T4 DNA ligase, require long incubation times, high concentrations, and low ATP levels to efficiently ligate single-stranded DNA oligonucleotides splinted by complementary RNA, and are inefficient in forming adenylated DNA side products, limiting their utility in RNA-mediated annealing and ligation techniques.
Innovation Solution
The use of PBCV-1 RNA splint ligase, which operates at a molar ratio of greater than 100:1 with polynucleotides, in a buffer containing 1 μM-1.5 mM ATP, allowing for efficient ligation of single-stranded polynucleotides splinted by RNA, achieving 70%-90% ligation in less than 6 hours, and demonstrating superior activity compared to T4 DNA ligase.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If T4 DNA ligase is used for ligation of RNA-splinted DNA oligonucleotides, then ligation can be achieved, but the reaction requires long incubation times and high ligase concentrations
Solution Approach 1:
The patent changes the fundamental parameter of ligase type from T4 DNA ligase to PBCV-1 DNA ligase, which has inherently different catalytic properties. PBCV-1 ligase naturally accepts RNA-splinted DNA substrates with high efficiency without requiring extended incubation times or high enzyme concentrations, thus resolving the contradiction between ligation reliability and time consumption
Solution Approach 2:
The patent identifies and utilizes a natural ligase system (PBCV-1 DNA ligase) that has evolved to specifically handle RNA-splinted DNA substrates. This natural copy of the solution found in virology directly addresses the artificial problem created by using T4 ligase for RNA-mediated ligation applications
2Reliability
If T4 DNA ligase is used for ligation, then ligation product is formed, but adenylated DNA side products are preferentially formed reducing ligation efficiency
Solution Approach 1:
The patent changes the enzymatic parameters by substituting T4 DNA ligase with PBCV-1 DNA ligase, which has different substrate specificity and catalytic mechanisms. PBCV-1 ligase produces minimal adenylated DNA side products while maintaining high ligation efficiency, thus resolving the contradiction between desired ligation and unwanted side reactions
Solution Approach 2:
The patent turns the previously harmful side reaction into a beneficial outcome by using PBCV-1 ligase, which naturally minimizes adenylated DNA formation. This converts the harmful effect into a benefit where the ligase system inherently prevents side product formation while maintaining high productivity
3Productivity
If PBCV-1 RNA splint ligase is used, then ligation rate increases up to 10 times faster, but enzyme concentration requirements change
Solution Approach 1:
The patent changes the concentration parameter from high (required by T4 ligase) to low (sufficient for PBCV-1 ligase). PBCV-1 DNA ligase achieves 10-fold higher ligation rates at much lower enzyme concentrations, resolving the contradiction between productivity and quantity of substance by operating in a different concentration regime
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
PBCV-1 RNA splint ligase enables rapid and efficient ligation of RNA-splinted DNA oligonucleotides, reducing background amplification and increasing ligation rates up to 10 times faster than T4 DNA ligase, with improved stability and efficiency in RNA-mediated techniques like RASL and molecular inversion probes.
Implementation Method 1
PBCV-1 RNA splint ligase enables rapid and efficient ligation of RNA-splinted DNA oligonucleotides
Implementation Method 2
single-stranded polynucleotide fragments hybridized to an RNA template or splint
Data Source
AI summary
Compositions and methods are provided for ligating polynucleotides having a length that is greater than 8 nucleotides on an RNA splint. The ligation reaction provides consistent results in high or low ATP concentrations. The reaction can occur rapidly and is generally at least 10 fold more efficient than T4DNA ligase under optimal conditions for T4DNA ligase and the reaction time is less than 6 hours for example, less than 1 hour.